| Description |
| CD30 MicroBeads were developed for the enrichment or the depletion of Hodgkin/Reed-Sternberg cells or activated B cells and T cells from different human tissues including peripheral blood, lymph nodes, tonsils, and bone marrow. For activated T cells, click here, for activated B cells, click here. |
| Applications |
| The rare and fragile Hodgkin/Reed-Sternberg cells isolated with CD30 MicroBeads have been used for phenotypic and genotypic analyses. For combined enrichment and detection, CD30 MicroBeads are provided in combination with CD30-PE. |
| |
| Figure 1 |
| This CD30+ Hodgkin/Reed-Sternberg cell was isolated by MACS® Technology from a lymph node of a patient with Hodgkin's disease. (Courtesy of Dr. Johannes Irsch, Cologne, Germany.) |
 |
|
| Figure 2 |
| Isolation and counterstaining of CD30+ cells from a lymph node affected by the nodular sclerosis subtype of Hodgkin's disease. |
| A: Before enrichment |
 |
| B: After enrichment |
 |
|
|
